Sage Therapeutic Com (SAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 41,243 | 86,455 | 7,686 | 6,308 | 1,114,200 |
| Cost of Goods | 9,444 | 2,159 | 813 | 553 | 565 |
| Gross Profit | 31,799 | 84,296 | 6,873 | 5,755 | 1,113,635 |
| Operating Expenses | 464,613 | 664,304 | 554,675 | 467,217 | 517,974 |
| Operating Income | -432,370 | -579,849 | -546,989 | -460,909 | 596,226 |
| Other Income | 31,704 | 38,360 | 14,205 | 3,017 | 9,847 |
| Pre-tax Income | -400,666 | -541,489 | -532,784 | -457,892 | 606,073 |
| Net Income Continuous | -400,666 | -541,489 | -532,784 | -457,892 | 606,073 |
| Net Income | $-400,666 | $-541,489 | $-532,784 | $-457,892 | $606,073 |
| EPS Basic Total Ops | -6.59 | -9.05 | -8.98 | -7.80 | 11.66 |
| EPS Basic Continuous Ops | -6.59 | -9.05 | -8.98 | -7.80 | 11.66 |
| EPS Diluted Total Ops | -6.59 | -9.05 | -8.98 | -7.80 | 11.43 |
| EPS Diluted Continuous Ops | -6.59 | -9.05 | -8.98 | -7.80 | 11.43 |
| EPS Diluted Before Non-Recurring Items | -6.59 | -8.49 | -8.98 | -7.80 | -9.47 |
| EBITDA(a) | $-437,820 | $-584,796 | $-540,014 | $-443,681 | $599,904 |